Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Quant Healthcare Fund Reg (G) |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Equity |
99.40 |
GOI Securities |
2.69 |
Trep |
-2.09 |
|
|
Concentration Analysis |
Top 5 Holdings |
42.80% |
Top 10 Holdings |
76.36% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
68.41 |
Healthcare |
11.6 |
Petroleum Products |
6.69 |
Food Beverage & Tobacco |
5.83 |
Telecom |
5.11 |
SOV |
2.69 |
Derivatives |
1.76 |
Cash |
-2.09 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.12 |
PE Ratio |
21.30 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
DIVI LABORATORIES LTD |
9.57 |
RPG Life Sciences Limited |
9.28 |
Aster DM Healthcare Limited |
9.22 |
IPCA Laboratories Limited |
7.42 |
Torrent Pharmaceuticals Limited |
7.31 |
Alivus Life Sciences |
7.20 |
Zydus Lifesciences Limited |
7.02 |
Aurobindo Pharma Limited |
6.82 |
Reliance Industries Limited |
6.69 |
Zydus Wellness Limited |
5.83 |
Pfizer Limited |
5.22 |
HFCL Limited |
5.11 |
SEQUENT SCIENTIFIC LTD |
4.76 |
SMS Pharmaceuticals Limited |
3.81 |
91 Days Treasury Bill 24-Apr-2025 |
2.69 |
SURAKSHA DIAGNOSTIC LTD |
2.38 |
Dr. Reddys Laboratories Limited 24/04/2025 |
1.17 |
TREPS 02-Apr-2025 DEPO 10 |
0.66 |
Aurobindo Pharma Limited 24/04/2025 |
0.59 |
NCA-NET CURRENT ASSETS |
-2.75 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|